technetium tc 99m sestamibi has been researched along with Diabetic Foot in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bem, R; Buncova, M; Dubsky, M; Fejfarova, V; Jirkovska, A; Nemcova, A; Pysna, A; Woskova, V | 1 |
| Atay, T; Baykal, YB; Burc, H; Yaman, E; Yıldız, M; Yorgancigil, H | 1 |
2 other study(ies) available for technetium tc 99m sestamibi and Diabetic Foot
| Article | Year |
|---|---|
Perfusion scintigraphy in the assessment of autologous cell therapy in diabetic patients with critical limb ischemia.
Topics: Aged; Cell- and Tissue-Based Therapy; Diabetes Mellitus, Type 2; Diabetic Foot; Female; Humans; Leg; Male; Middle Aged; Perfusion Imaging; Technetium Tc 99m Sestamibi; Transplantation, Autologous | 2018 |
Is scintigraphy a guideline method in determining amputation levels in diabetic foot?
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Cohort Studies; Decision Making; Diabetic Foot; Female; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Practice Guidelines as Topic; Preoperative Care; Prospective Studies; Radionuclide Imaging; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Technetium Tc 99m Sestamibi; Treatment Outcome; Wound Healing | 2014 |